Please ensure Javascript is enabled for purposes ofwebsite accessibility
Close Alert

Maryland's Novavax working on its version of COVID-19 vaccine to target omicron variant


Novavax Scientist Conducting Vaccine Development Research (Credit: Novavax)
Novavax Scientist Conducting Vaccine Development Research (Credit: Novavax)
Facebook Share IconTwitter Share IconEmail Share Icon
Loading ...